EUS-guided versus percutaneous liver biopsy: Do we have a winner?
- PMID: 36255021
- PMCID: PMC9688141
- DOI: 10.4103/EUS-D-22-00102
EUS-guided versus percutaneous liver biopsy: Do we have a winner?
Conflict of interest statement
None
References
-
- Menghini G. One-second needle biopsy of the liver. Gastroenterology. 1958;35:190–9. - PubMed
-
- Khurana S, Butt W, Khara HS, et al. Bi-lobar liver biopsy via EUS enhances the assessment of disease severity in patients with non-alcoholic steatohepatitis. Hepatol Int. 2019;13:323–9. - PubMed
-
- Pineda JJ, Diehl DL, Miao CL, et al. EUS-guided liver biopsy provides diagnostic samples comparable with those via the percutaneous or transjugular route. Gastrointest Endosc. 2016;83:360–5. - PubMed
-
- Bazerbachi F, Vargas EJ, Matar R, et al. EUS-guided core liver biopsy sampling using a 22-gauge fork-tip needle: A prospective blinded trial for histologic and lipidomic evaluation in nonalcoholic fatty liver disease. Gastrointest Endosc. 2019;90:926–32. - PubMed
